|
Dec 6
|
Zacks.com featured highlights Abercrombie & Fitch, Amphastar and NetEase
|
|
Dec 5
|
Are You Looking for a Top Momentum Pick? Why Amphastar Pharmaceuticals (AMPH) is a Great Choice
|
|
Dec 4
|
Amphastar, Stock Of The Day, Breaks Out As It Sees Upside From Eli Lilly Deal
|
|
Nov 30
|
This Biotech Stock Nears A Buy Point After 200% Profit Growth
|
|
Nov 29
|
Amphastar (AMPH) Is Considered a Good Investment by Brokers: Is That True?
|
|
Nov 8
|
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2023
|
|
Nov 4
|
Amphastar Pharmaceuticals' (NASDAQ:AMPH) 42% YoY earnings expansion surpassed the shareholder returns over the past three years
|
|
Oct 2
|
Amphastar Pharmaceuticals (AMPH) Stock Sinks As Market Gains: What You Should Know
|
|
Aug 11
|
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
|
|
Aug 11
|
Is Amphastar (AMPH) a Solid Growth Stock? 3 Reasons to Think "Yes"
|
|
Aug 11
|
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
|
|
Aug 11
|
Is Amphastar Pharmaceuticals (AMPH) Stock Outpacing Its Medical Peers This Year?
|
|
Aug 10
|
Dr. Reddy's Laboratories Ltd (RDY) Hits Fresh High: Is There Still Room to Run?
|
|
Aug 9
|
Q2 2023 Amphastar Pharmaceuticals Inc Earnings Call
|
|
Aug 9
|
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates
|
|
Aug 8
|
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2023
|